title: Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
abstract: We present a report of the use of interferon-beta before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated.
authors.affiliation: Department of Neuropediatrics, Saint-Vincent de Paul Hospital, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Mikaeloff
authors.forename: T
authors.initials: T
authors.lastname: Moreau
authors.forename: M
authors.initials: M
authors.lastname: Debouverie
authors.forename: J
authors.initials: J
authors.lastname: Pelletier
authors.forename: C
authors.initials: C
authors.lastname: Lebrun
authors.forename: O
authors.initials: O
authors.lastname: Gout
authors.forename: J M
authors.initials: JM
authors.lastname: Pedespan
authors.forename: C
authors.initials: C
authors.lastname: Van Hulle
authors.forename: P
authors.initials: P
authors.lastname: Vermersch
authors.forename: G
authors.initials: G
authors.lastname: Ponsot
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta